Woodfield SE - Search Results

1

Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.

Sumazin P, Peters TL, Sarabia SF, Kim HR, Urbicain M, Hollingsworth EF, Alvarez KR, Perez CR, Pozza A, Najaf Panah MJ, Epps JL, Scorsone K, Zorman B, Katzenstein H, O'Neill AF, Meyers R, Tiao G, Geller J, Ranganathan S, Rangaswami AA, Woodfield SE, Goss JA, Vasudevan SA, Heczey A, Roy A, Fisher KE, Alaggio R, Patel KR, Finegold MJ, López-Terrada DH. Sumazin P, et al. Among authors: woodfield se. J Hepatol. 2022 Oct;77(4):1026-1037. doi: 10.1016/j.jhep.2022.04.035. Epub 2022 May 14. J Hepatol. 2022. PMID: 35577029 Free PMC article.

2

The novel kinase inhibitor EMD1214063 is effective against neuroblastoma.

Scorsone K, Zhang L, Woodfield SE, Hicks J, Zage PE. Scorsone K, et al. Among authors: woodfield se. Invest New Drugs. 2014 Oct;32(5):815-24. doi: 10.1007/s10637-014-0107-4. Epub 2014 May 16. Invest New Drugs. 2014. PMID: 24832869

3

Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B.

Woodfield SE, Guo RJ, Liu Y, Major AM, Hollingsworth EF, Indiviglio S, Whittle SB, Mo Q, Bean AJ, Ittmann M, Lopez-Terrada D, Zage PE. Woodfield SE, et al. Genes Cancer. 2016 Jan;7(1-2):13-26. doi: 10.18632/genesandcancer.97. Genes Cancer. 2016. PMID: 27014418 Free PMC article.

4

The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma.

Whittle SB, Patel K, Zhang L, Woodfield SE, Du M, Smith V, Zage PE. Whittle SB, et al. Among authors: woodfield se. Invest New Drugs. 2016 Dec;34(6):685-692. doi: 10.1007/s10637-016-0387-y. Epub 2016 Sep 1. Invest New Drugs. 2016. PMID: 27586230

5

Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma.

Mao X, Chen Z, Zhao Y, Yu Y, Guan S, Woodfield SE, Vasudevan SA, Tao L, Pang JC, Lu J, Zhang H, Zhang F, Yang J. Mao X, et al. Among authors: woodfield se. Oncotarget. 2017 Jan 3;8(1):1555-1568. doi: 10.18632/oncotarget.13657. Oncotarget. 2017. PMID: 27902463 Free PMC article.

6

A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma.

Woodfield SE, Shi Y, Patel RH, Jin J, Major A, Sarabia SF, Starosolski Z, Zorman B, Gupta SS, Chen Z, Ibarra AM, Bissig KD, Ghaghada KB, Sumazin P, López-Terrada D, Vasudevan SA. Woodfield SE, et al. Sci Rep. 2017 Dec 19;7(1):17751. doi: 10.1038/s41598-017-17665-8. Sci Rep. 2017. PMID: 29259231 Free PMC article.

7

Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo.

Chen Z, Zhao Y, Yu Y, Pang JC, Woodfield SE, Tao L, Guan S, Zhang H, Bieerkehazhi S, Shi Y, Patel R, Vasudevan SA, Yi JS, Muscal JA, Xu GT, Yang J. Chen Z, et al. Among authors: woodfield se. Oncotarget. 2017 Oct 24;8(61):104090-104103. doi: 10.18632/oncotarget.22011. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262623 Free PMC article.

8

Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation.

Jin J, Jin J, Woodfield SE, Patel RH, Jin NG, Shi Y, Liu B, Sun W, Chen X, Yu Y, Vasudevan SA. Jin J, et al. Among authors: woodfield se. Oncol Rep. 2019 Jan;41(1):143-153. doi: 10.3892/or.2018.6793. Epub 2018 Oct 15. Oncol Rep. 2019. PMID: 30320362 Free PMC article.

9

Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma.

Yu Y, Zhao Y, Fan Y, Chen Z, Li H, Lu J, Guo K, Woodfield SE, Vasudevan SA, Yang J, Nuchtern JG. Yu Y, et al. Among authors: woodfield se. Mol Cancer Ther. 2019 Jun;18(6):1045-1056. doi: 10.1158/1535-7163.MCT-18-0146. Epub 2019 Apr 8. Mol Cancer Ther. 2019. PMID: 30962318 Free PMC article.

10

Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling.

Li H, Yu Y, Zhao Y, Wu D, Yu X, Lu J, Chen Z, Zhang H, Hu Y, Zhai Y, Su J, Aheman A, De Las Casas A, Jin J, Xu X, Shi Z, Woodfield SE, Vasudevan SA, Agarwal S, Yan Y, Yang J, Foster JH. Li H, et al. Among authors: woodfield se. Cancer Lett. 2019 Aug 10;457:129-141. doi: 10.1016/j.canlet.2019.05.011. Epub 2019 May 14. Cancer Lett. 2019. PMID: 31100410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page